Renovaro

Renovaro Biosciences

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Wall-Street_1 copy

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

BAOS

CHEK

CREV

JTAI

RENB

SLGL

US Stocks Gain, Nasdaq Surges Over 100 Points

movers image

Pre-Market Outlook

Movers

AVGR

AZTR

BDSX

BURU

CETX

ELAB

OCFT

SAVE

SMMT

SNAL

SOBR

TIGR

UAVS

Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket

AGRI

AILE

BCDA

CELH

CLEU

CMLS

CRWD

DERM

EFSH

ENSV

ESPR

FCEL

GERN

GMGI

HOUS

HOVR

ICCH

LENZ

MLGO

NISN

NVAX

OPRA

PERI

PRST

ROMA

SBFM

SIFY

SKYE

SMHI

SPEC

SYNX

TELL

THAR

TNXP

TPHS

VRAX

WETH

WLDS

Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Renovaro Inc

renBTC

Press Releases

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Renovaro Issues Shareholder Letter and Provides Corporate Update

Management

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Small Cap

Opinion

Investors Eye Biotech Sector as Cancer Therapy Market Surges

Renovaro Announces $15 million in Equity Committed

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB)

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

GRAL

ONCY

POAI

TSX:ONC

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Avalo Therapeutics

Cabaletta Bio

CAMP4 Therapeutics Corporation - Common Stock

Camp4 Therapeutics

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

HilleVax

IGM Biosciences

I-MAB

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

IO Biotech

Invivyd

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

Macrogenics

MediciNova

Pyxis Oncology

Quince Therapeutics

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

TScan Therapeutics

Vor Biopharma

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

Zura Bio Limited - Class A Ordinary shares

Zura Bio

Screenshot 2024-05-06 at 6.05.33 PM

Biotech

General

NVDA

Renovaro Inc. (NASDAQ: RENB) Aims To Revolutionize Cancer Detection And Treatment Using Multi-Cancer Detection Model With Nvidia AI Chips For Leadership In Early Detection

Comments

Renovaro

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga